From 17 August, insured people gain access to 18 more prescription medicines
Prime Minister Đuro Macut announced that, from 17 August, insured people in Serbia will be entitled to 18 more prescription medicines with state co-financing. The list includes 16 oral anticoagulants and two medicines for certain heart-failure patients. According to N1 and 021, the state will cover 70% of the anticoagulants’ price, reducing the co-payment to roughly RSD 600–1,100 per pack.
What matters
18 medicines
The list is to include 16 oral anticoagulants and two medicines for certain heart-failure patients.
Anticoagulant co-payment
The state is to cover 70% of the price; the stated co-payment is roughly RSD 600–1,100 instead of about RSD 1,700–6,000.
Heart failure
For the two medicines, the stated co-payment is about RSD 1,700 per pack; eligibility depends on the individual diagnosis and clinician.
Breakdown by publication
How sources frame this story
Mobile shows the first 2; the full breakdown is available on desktop.
N1: 18 more prescription medicines from 17 August
N1 relays the prime minister’s statement that 16 anticoagulants and two medicines for some heart-failure patients will be listed, with indicative co-payments.
021: 18 more prescription medicines from 17 August
021 gives the same start date, 16 anticoagulants and two heart-failure medicines, as well as indicative co-payments.
Overall takeaway
The announcement concerns eligibility for new list entries from 17 August, not an automatic removal of every co-payment: the conditions and amount depend on the medicine and prescription.
What this means for residents
Check prescription eligibility
The measure starts on 17 August; ask a clinician or pharmacy whether the individual medicine and diagnosis are covered by the new listing.
This is a separate phase
The new listings supplement lower co-payments for 769 prescription medicines that have applied since 1 August.